Diverse Applications of the Anti-Diabetic Drug Metformin in Treating Human Disease

被引:1
|
作者
Roberts, Chris-Tiann [1 ]
Raabe, Nicole [1 ]
Wiegand, Lara [1 ]
Shahib, Ashraf Kadar [1 ]
Rastegar, Mojgan [1 ]
机构
[1] Univ Manitoba, Rady Fac Hlth Sci, Dept Biochem & Med Genet, Max Rady Coll Med, Winnipeg, MB R3E 0J9, Canada
基金
加拿大健康研究院;
关键词
metformin; drug repurposing; epigenetics; human disease; type; 2; diabetes; ORGANIC CATION TRANSPORTERS; EPIGENETIC MECHANISMS; SPATIAL MEMORY; BRAIN-BARRIER; GLUCOSE; EXPRESSION; COMPLEX; AUTOPHAGY; PROTECTS; MODEL;
D O I
10.3390/ph17121601
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Metformin is a commonly used drug for treating type 2 diabetes. Metformin is an inexpensive drug with low/no side effects and is well tolerated in human patients of different ages. Recent therapeutic strategies for human disease have considered the benefits of drug repurposing. This includes the use of the anti-diabetic drug metformin. Accordingly, the anti-inflammatory, anti-cancer, anti-viral, neuroprotective, and cardioprotective potentials of metformin have deemed it a suitable candidate for treating a plethora of human diseases. As results from preclinical studies using cellular and animal model systems appear promising, clinical trials with metformin in the context of non-diabetes-related illnesses have been started. Here, we aim to provide a comprehensive overview of the therapeutic potential of metformin in different animal models of human disease and its suggested relationship to epigenetics and ailments with epigenetic components.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] Metformin, an Anti-diabetic Drug to Target Leukemia
    Biondani, Giulia
    Peyron, Jean-Francois
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [2] Metformin: A metabolic disruptor and anti-diabetic drug to target human leukemia
    Rosilio, Celia
    Ben-Sahra, Issam
    Bost, Frederic
    Peyron, Jean-Francois
    CANCER LETTERS, 2014, 346 (02) : 188 - 196
  • [3] Metformin: An anti-diabetic drug to fight cancer
    Daugan, Marie
    Wojcicki, Amelie Dufay
    d'Hayer, Benoit
    Boudy, Vincent
    PHARMACOLOGICAL RESEARCH, 2016, 113 : 675 - 685
  • [4] METFORMIN - FROM ANTI-DIABETIC DRUG TO ANTI-CANCER DRUG
    Markowicz-Piasecka, Magdalena
    Huttunen, Kristiina M.
    Mikiciuk-Olasik, Elzbieta
    Mateusiak, Lukasz
    Sikora, Joanna
    ACTA POLONIAE PHARMACEUTICA, 2018, 75 (01): : 3 - 18
  • [5] Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats
    Gao, Ying
    Li, Yunfeng
    Xue, Jing
    Jia, Yongqian
    Hu, Jing
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 635 (1-3) : 231 - 236
  • [6] Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy
    Snima, Kaniyampadi Sreenivasan
    Pillai, Prathesha
    Cherian, Aleena Mary
    Nair, Shantikumar V.
    Lakshmanan, Vinoth-Kumar
    CURRENT CANCER DRUG TARGETS, 2014, 14 (08) : 727 - 736
  • [7] Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture
    Cortizo, AM
    Sedlinsky, C
    McCarthy, AD
    Blanco, A
    Schurman, L
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 536 (1-2) : 38 - 46
  • [8] The role of an anti-diabetic drug metformin in the treatment of endocrine tumors
    Thakur, Shilpa
    Daley, Brianna
    Klubo-Gwiezdzinska, Joanna
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2019, 63 (02) : R17 - R35
  • [9] Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo
    Miyoshi, Hisaaki
    Kato, Kiyohito
    Iwama, Hisakazu
    Maeda, Emiko
    Sakamoto, Teppei
    Fujita, Koji
    Toyota, Yuka
    Tani, Joji
    Nomura, Takako
    Mimura, Shima
    Kobayashi, Mitsuyoshi
    Morishita, Asahiro
    Kobara, Hideki
    Mori, Hirohito
    Yoneyama, Hirohito
    Deguchi, Akihiro
    Himoto, Takashi
    Kurokohchi, Kazutaka
    Okano, Keiichi
    Suzuki, Yasuyuki
    Murao, Koji
    Masaki, Tsutomu
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (01) : 322 - 332
  • [10] Adsorption of Metformin as Anti-Diabetic Drug On Carbon Nanotube and Activated Carbon
    Lotfi, Hassan
    Abadi, Raziyh Jafari Khoshan
    Vadi, Mehdi
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2015, 6 (03): : 1422 - 1427